BackgroundTreating severe pneumonia caused by multiple pathogens in immunocompromised hosts (ICHs) presents significant challenges. Isavuconazole (ISA). a next-generation triazole antifungal agent. has shown promise in managing fungal infections. https://www.chiggate.com/3m-speedglas-9002nc-welding-helmet-fashion/